A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern.
Yang J, Liu MQ, Liu L, Li X, Xu M, Lin H, Liu S, Hu Y, Li B, Liu B, Li M, Sun Y, Chen YQ, Shi ZL, Yan H.
Yang J, et al. Among authors: li x, li m, li b.
Cell Mol Immunol. 2022 Nov;19(11):1279-1289. doi: 10.1038/s41423-022-00929-3. Epub 2022 Oct 11.
Cell Mol Immunol. 2022.
PMID: 36220993
Free PMC article.